Announcements Trials
Browse Landscape

Status

Recruiting 2Withdrawn 1Completed 1

Sponsor Class

OTHER 4

Study Type

Observational 4

Sponsor

Cancer Type

Genitourinary 5Gastrointestinal 4Tumor-Agnostic 3Thoracic 2Other hematologic neoplasm 2Plasma cell 1Myeloid 1Head & Neck 1Classical hematology 1Breast 1

Conditions

Pancreatic Neoplasms 1PDAC - Pancreatic Ductal Adenocarcinoma 1Non Metastatic Rectal Cancer 1Colonic Neoplasms 1

Interventions

Oxaliplatin 1435Fluorouracil 1316Capecitabine 1112Gemcitabine 1054Leucovorin 935Bevacizumab 845Irinotecan 827Cisplatin 673Radiotherapy 559Cetuximab 481pembrolizumab 435Paclitaxel 400Drug Therapy 358Nivolumab 349130-nm albumin-bound paclitaxel 326Docetaxel 289Sorafenib 288S 1 (combination) 278Folfox protocol 266Albumin-Bound Paclitaxel 263Surgical Procedures, Operative 256lenvatinib 222sintilimab 218tislelizumab 213durvalumab 211regorafenib 208Radiosurgery 204Magnetic Resonance Spectroscopy 203apatinib 202Neoadjuvant Therapy 190

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Registries × Gastrointestinal × Clear all
NCT02674100 2025-02-25

American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry

University of Louisville

Recruiting
500 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT05845801 2023-05-06

PanC-YOUNG

Azienda Ospedaliera Universitaria Integrata Verona

Recruiting
3,000 enrolled
Gastrointestinal

PDAC - Pancreatic Ductal Adenocarcinoma

NCT04045236 2023-03-23

FUCORE

Niguarda Hospital

Withdrawn
Gastrointestinal

Non Metastatic Rectal Cancer

NCT01310972 2018-08-10

Adjuvant Colon Cancer w/ ELOXatin®/5 FU Based Regimen: ACCELOX

King Faisal Specialist Hospital & Research Center

Completed
6 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡